Page last updated: 2024-08-22

poloxalene and rhodamine b

poloxalene has been researched along with rhodamine b in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Melo, MT; Paula, LB; Pellosi, DS; Tedesco, AC	1

Other Studies

1 other study(ies) available for poloxalene and rhodamine b

Article	Year
Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy. Molecular pharmaceutics, 2019, 03-04, Volume: 16, Issue:3 Topics: Animals; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Drug Compounding; Drug Liberation; Drug Stability; Drug Synergism; Glioblastoma; Humans; Mice; Microscopy, Atomic Force; Microscopy, Confocal; Nanoparticles; NIH 3T3 Cells; Particle Size; Poloxalene; Rhodamines; Temozolomide; Verteporfin	2019

Article

Year

Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy.

Molecular pharmaceutics, 2019, 03-04, Volume: 16, Issue:3

Topics: Animals; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Drug Compounding; Drug Liberation; Drug Stability; Drug Synergism; Glioblastoma; Humans; Mice; Microscopy, Atomic Force; Microscopy, Confocal; Nanoparticles; NIH 3T3 Cells; Particle Size; Poloxalene; Rhodamines; Temozolomide; Verteporfin

2019